Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis-Challenges of Recognition and Management

Journal of Association of Physicians of India

Volumn 48, Issue 10, 2000, Pages 999-1003

  Sane, S P ^a   Bhatt, A D ^a  

^a Novartis India Limited   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG HYPERSENSITIVITY; FEMALE; HUMAN; INDIA; MALE; PROGNOSIS; REVIEW; RISK ASSESSMENT; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

DRUG HYPERSENSITIVITY; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; INDIA; MALE; PROGNOSIS; RISK ASSESSMENT; STEVENS-JOHNSON SYNDROME;

EID: 0034302625     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Rieder MJ. Mechanism of unpredictable adverse drug reactions. Drug Safety 1994; 11 : 196-212.
2. Anderson JA. Allergic reactions to drugs and biological agents. JAMA 1992; 268 : 2845-57.
3. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331 : 1272-85.
4. Weintraub MI. Medicolegal aspects of iatrogenic injuries. Neurol Clin N Am 1998; 16 : 217-27.
5. Stevens AM, Johnson FC. A new eruptive fever associated with stomatitis, and ophthalmia : report of two cases in children. Am J Dis Child 1922; 24 : 526-33.
6. Lyell A. Toxic epidermal necrolysis : An eruption resembling scalding of the skin. Br J Dermatol 1956; 68 : 355-61.
7. Bastuji-Garins, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome and erythema multiforme. Arch Dermatol 1993; 129 : 92-6.
8. Becker DS. Toxic epidermal necrolysis. Lancet 1998; 351 : 1417-20.
9. Roujeau JC. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis : a clinical classification. J Invest Dermatol 1994; 102 : 28S-30S.
10. Wolkenstein P, Revuz J. Drug induced severe skin reactions - incidence, management and prevention. Drug Safety 1995; 13 : 56-68.
11. Baur S, Rzany B, Mockenhaupt M, et al. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in West Germany and Berlin among different ethnic groups. J Invest Dermatol 1994; 102 : 619.
12. Revuz JE, Roujeau JC. Advances in toxic epidermal necrolysis. Semin Cutan Med Surg 1996; 15 : 258-66.
13. Bork K. Toxic epidermal necrolysis (Lyell's Syndrome) and Erythema multiforme. In : Cutaneous side effects of drugs, WB Saunders, Philadelphia. 1988; 122-46.
14. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333 : 1600-7.
15. Schlienger RG, Shapiro LE, Shear NH. Lamotrigine induced severe cutaneous adverse reactions. Eilepsia 1998; 39 (S7) : s22-6.
16. Bhattacharya SK, Singh NK, Prasad RC, et al. Some unusual and severe forms of adverse drug reactions : a call for setting adverse drug reaction monitoring centres. J Assoc Physicians India 1998; 46 : 675-7.
17. Taneja A, Gupte PD, Mangalvedhekar SS, et al. Stevens-Johnson syndrome - results of a three year study in KEM Hospital. The Indian Practitioner 1998; 51 : 799-802.
18. Prendiville JS, Hebert AA, Greenwald MJ, et al. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Pediatr 1989; 115 : 881-7.
19. McGee T, Munster A. Toxic epidermal necrolysis syndrome : mortality rates reduced with early referral to regional burn centre. Plast Reconstr Surg 1998; 102 : 1018-22.
20. Kokourou T, Klontza D, Soteropoulou, et al. Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in children. Eur J Pediatr 1997; 156 : 90-3.
21. D'Souza P, Ramam M. Management of toxic epidermal necrolysis : role of corticosteroids in therapy. Hospital Today 1997; 2: 39-41.
22. Sharma VK, Dhar S. Clinical pattern of cutaneous drug eruptions among children and adolescents in North India. Pediatr Dermatol 1995; 12 : 178-83.
23. Guibal F, Bastuji-Garin S, Chosidow O, et al. Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dermatol 1995; 131 : 669-72.
24. Power WJ, Ghoraishi M, Merayo-Iloves J, et al. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome / toxic epidermal necrolysis disease spectrum. Ophthalmology 1995; 102 : 669-76.
25. Pasricha JS. Management of TEN. Ind J Dermatol Venerol Leprol 1990; 56 : 458-9.
26. Wolkenstein P, Chosidow O, Flechet ML, et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996; 35 : 234-6.
27. Sachs B, Ronnau AC, von Schmiedeberg S, et al. Lamotrigine induced Stevens-Johnson Syndrome : demonstration of specific lymphocyte reactivity in vitro. Dermatology 1997; 195 : 60-4.